Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs4444903
rs4444903
EGF
0.020 GeneticVariation BEFREE In conclusion, the current meta-analysis suggests that the G variant of the rs4444903 polymorphism may increase</span> the risk of liver cancer. 25299191

2014

dbSNP: rs5854292
rs5854292
0.010 GeneticVariation BEFREE Case-control studies assessing the relationship between TM6SF2 rs5854292 locus polymorphism and liver cancer were selected according to inclusion and exclusion criteria. 31752753

2019

dbSNP: rs3212948
rs3212948
0.010 GeneticVariation BEFREE The results of clinicopathologic analysis showed that A allele at the rs737241 locus could increase the expression level of AFP (P = .007), the rs1046282 mutation C allele could increase the AFP expression level (P = .011), rs4024 locus mutation A allele could reduce the risk of vascular invasion (P = .013), rs3212948 locus mutation T allele could reduce the differentiation of liver cancer (P = .022), rs1046282 locus C allele could reduce the DNA load of hepatitis B virus (P = .035), and rs735482 A allele could increase the tumor size in HCC (P = .037).The SNPs in rs737241 for AFP gene may correlate with the occurrence of HCC. 30946366

2019

dbSNP: rs735482
rs735482
0.010 GeneticVariation BEFREE The results of clinicopathologic analysis showed that A allele at the rs737241 locus could increase the expression level of AFP (P = .007), the rs1046282 mutation C allele could increase the AFP expression level (P = .011), rs4024 locus mutation A allele could reduce the risk of vascular invasion (P = .013), rs3212948 locus mutation T allele could reduce the differentiation of liver cancer (P = .022), rs1046282 locus C allele could reduce the DNA load of hepatitis B virus (P = .035), and rs735482 A allele could increase the tumor size in HCC (P = .037).The SNPs in rs737241 for AFP gene may correlate with the occurrence of HCC. 30946366

2019

dbSNP: rs1046282
rs1046282
0.010 GeneticVariation BEFREE The results of clinicopathologic analysis showed that A allele at the rs737241 locus could increase the expression level of AFP (P = .007), the rs1046282 mutation C allele could increase the AFP expression level (P = .011), rs4024 locus mutation A allele could reduce the risk of vascular invasion (P = .013), rs3212948 locus mutation T allele could reduce the differentiation of liver cancer (P = .022), rs1046282 locus C allele could reduce the DNA load of hepatitis B virus (P = .035), and rs735482 A allele could increase the tumor size in HCC (P = .037).The SNPs in rs737241 for AFP gene may correlate with the occurrence of HCC. 30946366

2019

dbSNP: rs867384693
rs867384693
0.010 GeneticVariation BEFREE Ultimately, P53 (N340Q/L344R) accerlerates the growth of liver cancer cells Hep3B by activating telomerase and prolonging telomere through the cascade of P53 (N340Q/L344R)-CUDR-PKM2-pH3T11- (H3K9me1-HP1α)-Pim1- (TERT-HOTAIR-TERRA). 27167190

2016

dbSNP: rs1799945
rs1799945
0.010 GeneticVariation BEFREE A number of previous studies have demonstrated that the HFE H63D polymorphism is associated with increased risk of incidence multiple types of cancer, including colorectal cancer, breast cancer, liver cancer, pancreatic cancer, and gynecological malignant tumors. 26535689

2015

dbSNP: rs1800562
rs1800562
0.010 GeneticVariation BEFREE A diagnosis of liver cancer or cirrhosis is rare in the lifetime of individuals from this population who are homozygous for the C282Y mutation (2.5%; upper 95% confidence interval (CI) = 8%). 10673304

2000

dbSNP: rs779555087
rs779555087
0.010 GeneticVariation BEFREE Particularly, HNF4α-D78A and HNF4α-G79S, two mutants found in liver cancer with mutations in DNA-binding domain, displayed highly gene-specific transactivation activities. 30191603

2019

dbSNP: rs11614913
rs11614913
0.010 GeneticVariation BEFREE This meta-analysis suggests that the miR-196a2 rs11614913 polymorphism may contribute to decreased susceptibility to cancer, especially including liver cancer and lung cancer. 24633889

2014

dbSNP: rs5498
rs5498
0.010 GeneticVariation BEFREE Moreover, gene and environment interactions of ICAM-1 rs5498 polymorphisms might alter susceptibility to liver cancer. 26341495

2016

dbSNP: rs1800871
rs1800871
0.010 GeneticVariation BEFREE Our objective was to examine the association between single nucleotide polymorphisms of interleukin (IL)-8 (rs4073 and rs2227306) and IL-10 (rs1800871 and rs1800872) genes, and clinical effects of transcatheter arterial chemoembolization (TACE) and subsequent prognosis in patients with liver cancer. 26400525

2015

dbSNP: rs1800872
rs1800872
0.010 GeneticVariation BEFREE Our objective was to examine the association between single nucleotide polymorphisms of interleukin (IL)-8 (rs4073 and rs2227306) and IL-10 (rs1800871 and rs1800872) genes, and clinical effects of transcatheter arterial chemoembolization (TACE) and subsequent prognosis in patients with liver cancer. 26400525

2015

dbSNP: rs1800795
rs1800795
0.010 GeneticVariation BEFREE Subgroup analyses of rs1800797 also suggested non-significant association and rs1800795 played a protective role in liver cancer. 29842912

2018

dbSNP: rs1800797
rs1800797
0.010 GeneticVariation BEFREE Subgroup analyses of rs1800797 also suggested non-significant association and rs1800795 played a protective role in liver cancer. 29842912

2018

dbSNP: rs1476081557
rs1476081557
0.010 GeneticVariation BEFREE We developed liver cancer cell lines that endogenously expressed a mutant form of TP53 (R249S) or overexpressed mutant forms of STAT3 (D170Y, K348E, and Y640F) or JAK1 (S703I and L910P) and tested the abilities of pharmacologic agents to reduce activity. 31560893

2019

dbSNP: rs764555290
rs764555290
0.010 GeneticVariation BEFREE Further study on expression level and relevant functional significance enables us to identify and conclude the following four novel variants, viz., c.416T>C (p.Phe139Ser) in SORD, c.1048_1049delGCinsCG (p.Ala350Arg) in KRT6A, c.1159G>T (p.Gly387Cys) in SVEP1, and c.430G>C (p.Gly144Arg) in MRPL38 as a critical genetic factor for liver cancer. 31272500

2019

dbSNP: rs367597251
rs367597251
0.010 GeneticVariation BEFREE Ras-carrying G12V and Y40C site mutation was transfected into liver cancer cell lines SNU-475 and SK-Hep-1. 31642074

2020

dbSNP: rs937283
rs937283
0.010 GeneticVariation BEFREE Specifically, the G allele of rs937283 conferred a significantly increased risk of breast and liver cancer</span>. 30244662

2018

dbSNP: rs1801133
rs1801133
0.020 GeneticVariation BEFREE After shrinkage and adjusting for potential confounding factors, we found positive associations between MTHFR rs1801133 and stomach cancer (any T versus C/C, SB odds-ratio [SBOR]: 1.79, 95% posterior limits: 1.18, 2.71) and liver cancer (SBOR: 1.51, 95% posterior limits: 0.98, 2.32). 25337902

2014

dbSNP: rs1801133
rs1801133
0.020 GeneticVariation BEFREE Therefore, MTHFR Ala222Val polymorphism is significantly associated with risk of hepatitis infection but not liver cancer</span>. 24155211

2014

dbSNP: rs1801131
rs1801131
0.010 GeneticVariation BEFREE Thus, Asian individuals with the homozygote genotype CC of MTHFR rs1801131 polymorphism are significantly associated with decreased risk of liver cancer. 24014085

2014

dbSNP: rs397507444
rs397507444
0.010 GeneticVariation BEFREE MTHFR rs1801131 (A1298C) polymorphism can decrease in vitro MTHFR enzyme activity and has been hypothesized to be associated with liver cancer risk. 24014085

2014

dbSNP: rs1805087
rs1805087
MTR
0.010 GeneticVariation BEFREE In addition, we detected potential heterogeneity across alcohol drinking status for ORs relating MTRR rs1801394 to esophageal (posterior homogeneity P = 0.005) and stomach cancer (posterior homogeneity P = 0.004), and ORs relating MTR rs1805087 to liver cancer (posterior homogeneity P = 0.021). 25337902

2014

dbSNP: rs1801394
rs1801394
0.010 GeneticVariation BEFREE In addition, we detected potential heterogeneity across alcohol drinking status for ORs relating MTRR rs1801394 to esophageal (posterior homogeneity P = 0.005) and stomach cancer (posterior homogeneity P = 0.004), and ORs relating MTR rs1805087 to liver cancer (posterior homogeneity P = 0.021). 25337902

2014